Form DEFA14A Spok Holdings, Inc
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant þ Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨ | Preliminary Proxy Statement | |||||||||||||
¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||||||||||||
¨ | Definitive Proxy Statement | |||||||||||||
þ | Definitive Additional Materials | |||||||||||||
¨ | Soliciting Material Pursuant to §240.14a-12 | |||||||||||||
SPOK HOLDINGS, INC. | ||||||||||||||
(Name of Registrant as Specified in its Charter) | ||||||||||||||
Payment of Filing Fee (Check all boxes that apply): | ||||||||||||||
þ | No fee required. | |||||||||||||
¨ | Fee paid previously with preliminary materials. | |||||||||||||
¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||||||||||||


Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LUX Announces First Anniversary Under Creative Capital Ownership With Exclusive Gianan Wine Collaboration
- Inspirit Senior Living Announces Strategic Combination with Venue Capital to Create Integrated Seniors Housing Platform
- Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share